key: cord-1007921-n99l1ler
authors: Behrendt, Christian-Alexander; Seiffert, Moritz; Gerloff, Christian; L’Hoest, Helmut; Acar, Laura; Thomalla, Götz
title: How does SARS-CoV-2 infection affect survival among patients with cardiovascular emergencies? A cohort study from a German insurance claims database
date: 2021-03-12
journal: Eur J Vasc Endovasc Surg
DOI: 10.1016/j.ejvs.2021.03.006
sha: 7b8ce70ee7969200c8577dad44f68d84fa6d33df
doc_id: 1007921
cord_uid: n99l1ler

Objective A previous study revealed a preliminary trend towards higher in-hospital mortality in patients emergently admitted with acute stroke during the COVID-19 pandemic in Germany. The current study aims to further examine the possible impact of a confirmed SARS-CoV-2 infection on in-hospital mortality. Methods This was a retrospective analysis of health insurance claims data from the second largest insurance fund in Germany, BARMER. Patients hospitalized for ST-elevation (STEMI) and non-ST-elevation (NSTEMI) myocardial infarction, acute limb ischaemia (ALI), aortic rupture, acute stroke, or transient ischaemic attack (TIA) between January 1, 2017, and October 31, 2020, were included. Admission rates per 10,000 insured and mortality were compared between March-June 2017-2019 (pre-COVID) and March-June 2020 (COVID). Mortality rates were determined by the occurrence of a confirmed SARS-CoV-2 infection. Results A total of 316,718 hospitalizations were included (48.7% female, mean 72.5 years), and 21,191 (6.7%, 95% CI 6.6-6.8%) deaths occurred. In-hospital mortality increased during the COVID-19 pandemic when compared to the three previous years for patients with acute stroke from 8.3% (95% CI 8.0-8.5) to 9.6% (95% CI 9.1-10.2) while no significant changes were observed for STEMI, NSTEMI, ALI, aortic rupture, and TIA. When comparing patients with confirmed SARS-CoV-2 infection (2.4%, 95% CI 2.3-2.5) vs. non-infected patients, a higher in-hospital mortality was observed for acute stroke (12.4% vs. 9.0%), ALI (14.3% vs. 5.0%), and TIA (2.7% vs. 0.3%) while no statistically significant differences were observed for STEMI, NSTEMI, and aortic rupture. Conclusion This retrospective analysis of claims data provided hints for an association of COVID-19 pandemic with increased in-hospital mortality in patients with acute stroke. Furthermore, confirmed SARS-CoV-2 infection was associated with increased mortality in patients with stroke, TIA, and ALI. Future studies are urgently needed to better understand the underlying mechanism and relationship between the new coronavirus and acute stroke.

The rapid spread of a new coronavirus (SARS-CoV-2) threw the global healthcare 83 system into turmoil. 1 Beginning with the implementation of infection control measures 84 during the first wave of the pandemic, the scientific community aimed to better 85 understand possible collateral damage in patients with emergent conditions. 2 In a 86 previous study using health insurance claims data, we observed declining admission 87 rates for cardiovascular and cerebrovascular emergencies in Germany. 3 These 88 findings confirmed the growing knowledge-base arising out of real-world data across 89 the globe. [4] [5] [6] [7] [8] Available outcome data in that previous study indicated a trend towards 90 increasing in-hospital mortality for acute stroke. 3 This observation was in line with 91 previous reports suggesting a particular impact of the pandemic on patients suffering 92 from neurovascular conditions. 4, [9] [10] [11] [12] [13] [14] 93 Only a few months later, the world faces a second pandemic wave, and numerous 94 questions remain unanswered in front of this upcoming challenge. 15, 16 Due to the 95 complex multimorbidity of patients with cardiovascular and cerebrovascular 96 emergencies, these patients are known to be at particular risk for a SARS-CoV-2 97 infection and unfavourable outcomes. 17 

For the current study, we used large, updated health insurance claims data and consensus guidelines determined that using anonymized data from claims or national 145 statistics retrospectively is not human subject research because de-identified 146 datasets were used. 22, 23 147 Statistical analysis 148 We summarized baseline characteristics of the patients with means and standard 149 deviation for age and with percentages for discrete variables. A comparison of 95% 150 confidence interval (CI) and two-proportion z-test was used to test for differences.

Rates per 10,000 insured were calculated on a monthly base. As sensitivity analysis, 152 we used both complete data from 2020 and data concerning only the four months 

We identified 316,718 hospitalizations (mean age 72.5 years, 48.7% females, 95% CI 165 48.6% to 48.9%) for cardiovascular or cerebrovascular emergencies between 166 January 1, 2017 and October 30, 2020 (monthly mean: 6,885 patients). Among all 167 hospitalizations, a total of 21,191 (6.7%, 95% CI 6.6% to 6.8%) deaths occurred. Using data concerning the entire study period, the monthly hospital admission rate for Table 3) . In-hospital mortality of patients admitted with acute stroke was negatively 188 associated with hospital admission rate. In patients admitted with STEMI, NSTEMI, 189 ALI, aortic rupture, and TIA, no association of in-hospital mortality with hospital 190 admission rate was observed. 3.0% (95% CI 2.7% to 3.3%) in patients admitted with NSTEMI ( Table 1 and 2) . 198 The in-hospital mortality of SARS-CoV-2 positive patients admitted with 199 cardiovascular and cerebrovascular emergencies was significantly higher when 200 compared to non-infected patients for acute stroke (12.4% vs. 9.0%), ALI (14.1% vs. were at only 25% the odds of stroke compared to other patients, but these stroke 253 patients had a 9-fold increase in mortality. 29 Again, the current study could confirm 254 these findings.

In light of these previous studies, the current study findings suggest that the COVID- Another interesting finding of the current study was related to the admission and 262 treatment of patients suffering from ALI. 18 In contrast to previous reports suggesting 263 an increasing rate of this emergency during the COVID-19 pandemic, the current 264 study observed rather stable admission rates. [30] [31] [32] However, the pronounced 265 association between confirmed SARS-CoV-2 infection and in-hospital mortality in 266 ALI-patients confirms that there is an underlying relation between both conditions. 267 From this study, it must be highlighted that the German healthcare system with its 268 distinct peculiarities in terms of hospital beds and intensive care infrastructure was 269 less affected than severely affected healthcare systems such as in Italy or Spain. admitted to legally endorsed hospitals were included. It appears possible that there is 298 a subgroup not covered because they decided not to use the emergency system.

The cardiovascular community should further support ongoing efforts to collect data 300 to protect our patients from evitable collateral damage. 33 With growing evidence for 301 an impact of COVID-19 on patients with acute stroke derived from real-world data, 302 we should pay particular attention to this vulnerable group. Increased awareness and 303 public recommendations to use emergency services may be reasonable. Copy editors: please note that only the critical style editing has been made to these tables. Full copy editing is still needed. I have used green background color to highlight the edits that should be repeated in the following columns in the same row (or, in Table 3 , in the following rows of the same column). Table 1 : Baseline characteristics of the cohort admitted to a legally endorsed German hospital between January 2017 and October 2020 for peripheral vascular emergencies. Data are presented as n (%) [95% confidence interval] or mean ± standard deviation, unless stated otherwise. TIA: Transient ischaemic attack. ALI: Acute limb ischaemia; N/A = not available.. Data are presented as n (%) [95% confidence interval] or mean ± standard deviation, unless stated otherwise. STEMI: ST-elevation myocardial infarction. NSTEMI: Non-ST-elevation myocardial infarction; N/A = not available Table 3 : In-hospital mortality for patients admitted for cardiovascular and cerebrovascular emergencies in March, April, May, and June before (2017-2019) vs. during (2020) the COVID pandemic.

Pattern of vascular disease in Lombardy, Italy, during the first month of the COVID-19 outbreak

The Need of Research Initiatives Amidst and After the Covid-19

Pandemic: A Message from the Editors of the EJVES

Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims

Collateral Effect of Covid-19 on Stroke Evaluation in the United States

Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy

Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage

Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic

Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic

Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona

SARS-CoV-2 and Stroke in a New York Healthcare System

Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke

Cerebrovascular Complications of COVID-19

European Multicenter Study of ET-COVID-19

Learn from the First Wave to Surf the Next One Optimally

Is it Possible to Safely Maintain a Regular Vascular Practice During the COVID-19 Pandemic?

Covid-19: risk factors for severe disease and death

Editor's Choice -European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia

Long Term Outcomes After Revascularisations Below the Knee with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis

Editor's Choice -Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health Insurance Claims Data

Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data

Quality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve? Gefässchirurgie 2020

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Impact of the COVID-19-pandemic on thrombectomy services in Germany

Ischemic Stroke Occurs Less Frequently in Patients With COVID-19

Acute limb ischemia in patients with COVID-19 pneumonia

Risk of peripheral arterial thrombosis in COVID-19

An increased severity of peripheral arterial disease in the COVID-19 era

Vascular Surgery COVID-19 Collaborative" (VASCC)

Change label for y-axis: "In-hospital mortality -%". In x-axis, write "rupture" and "stroke" with lower case first letters. Delete p<0.001 from x-axis. Change # to * in x-axis. Move colour labels below the graph area, use smaller and non-bold font. Change yellow to blue. Keep red in journal's red. Keep numbers for bars, but write them in smaller font and non-bold

The authors are grateful and sincerely acknowledge the submission of research data 315 from the BARMER, Germany.

The authors would like to thank Ursula Marschall (BARMER, Wuppertal, Germany) 317 for her support and scientific contributions to this project. The authors would also like